McKesson Agrees To Sell Its Canada-based Rexall And Well.ca Businesses To Birch Hill Equity Partners; No Terms Disclosed
Portfolio Pulse from Benzinga Newsdesk
McKesson Corporation has agreed to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners. The transaction aligns with McKesson's strategy to focus on its oncology and biopharma services platforms. The deal is subject to regulatory approvals.
September 05, 2024 | 10:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
McKesson Corporation is selling its Rexall and Well.ca businesses to Birch Hill Equity Partners, allowing McKesson to focus on its core oncology and biopharma services. The sale is pending regulatory approval.
The sale of Rexall and Well.ca allows McKesson to concentrate on its core business areas, which could lead to improved operational focus and potential growth in oncology and biopharma services. This strategic move is likely to be viewed positively by investors, potentially boosting MCK's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90